GSK-315234
GSK-315234 is a human IgG1 monoclonal antibody (mAb) targeting OSM . GSK-315234 can be used in the study of atherosclerosis Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001) [1].
Product Specifications
UNSPSC
12352203
Target
Interleukin Related
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Cardiovascular Disease
Purity
98.16
Smiles
[GSK-315234]
Molecular Weight
(146.41 kDa)
References & Citations
[1]Rankouhi TR, et al. Risks and Benefits of a Novel Therapeutic Target for Atherosclerosis. Curr Drug Targets. 2022;23 (14) :1345-1369.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1301162-01 0.02 mg (E-Coli)
Recombinant Hahella chejuensis Nucleoside diphosphate kinase (ndk)
Ask
View Details 
MBS1301162-02 0.1 mg (E-Coli)
Recombinant Hahella chejuensis Nucleoside diphosphate kinase (ndk)
Ask
View Details 
MBS1301162-03 0.02 mg (Yeast)
Recombinant Hahella chejuensis Nucleoside diphosphate kinase (ndk)
Ask
View Details MBS1301162-04 0.1 mg (Yeast)
Recombinant Hahella chejuensis Nucleoside diphosphate kinase (ndk)
Ask
View Details MBS1301162-05 0.02 mg (Baculovirus)
Recombinant Hahella chejuensis Nucleoside diphosphate kinase (ndk)
Ask
View Details